Primary Source Data: Driving Research, New Therapies, and Better Outcomes
Original, unaltered, and trustworthy – that’s the difference of primary source data.
For life sciences teams, primary source data unlocks research opportunities across HEOR, clinical trials, and market access, all of which ultimately make a meaningful impact on patients’ care journeys. With better research insights, more successful clinical trials, and clearer data to guide a new therapy’s brand strategy, patients have the most to benefit. Primary source data is working “behind the scenes” to make better care available across healthcare.
With over 300 million unique patients, Inovalon’s MORE2 Registry® is the industry’s largest primary source dataset. In this INOvators episode, Scott Jubeck, SVP of Product, Insights, shares how Inovalon’s Real-World Data™ can turn your next research initiative into valuable insights.
